NVCR
Novocure Ltd · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -20.0% ·
share flow +2.0% ·
net new positions -20.0%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 119.64K | $1.43M | n/a | n/a |
| Q2 2026 | 91 | +1 | 75.35M | $1.14B | +7 | −6 |
| Q1 2026 | 93 | -1 | 69.74M | $759.20M | +6 | −7 |
| Q4 2025 | 93 | -2 | 74.88M | $967.62M | n/a | −2 |
| Q3 2025 | 19 | 0 | 56.46M | $729.50M | n/a | n/a |
| Q2 2025 | 16 | +1 | 59.30M | $1.06B | +2 | −1 |
| Q1 2025 | 12 | -3 | 16.40M | $292.30M | n/a | −3 |
| Q4 2024 | 15 | +1 | 16.08M | $479.25M | +1 | n/a |
| Q3 2024 | 13 | 0 | 14.54M | $227.34M | n/a | n/a |
| Q2 2024 | 13 | n/a | 14.57M | $249.63M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 5.22M | +8.3% | $92.94M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passive) | 2.59M | -2.0% | $46.13M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (passive) | 2.46M | +2.6% | $43.91M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | Marshall Wace ✦ | 1.81M | +567.1% | $32.21M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 1.14M | -2.1% | $20.26M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 6 | Renaissance Technologies ✦ | 768.65K | +4.7% | $13.70M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Coatue Management ✦ | 608.67K | 0.0% | $10.85M | 0.0% | Held | 4 | SEC ↗ |
| 8 | Millennium Management ✦ | 551.26K | -25.0% | $9.82M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 9 | T. Rowe Price ✦ | 482.03K | -71.4% | $8.59M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 429.71K | -23.4% | $7.66M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 320.73K | +492.4% | $5.72M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 12 | AQR Capital Management ✦ | 28.73K | +56.7% | $511,933 | 0.0% | ▲ Add | 4 | SEC ↗ ×5 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Adage Capital Partners | $5.96M | was 0.0% |
| D. E. Shaw & Co. | $5.52M | was 0.0% |
| Bridgewater Associates | $331,346 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 221 holders, 97.96M shares, $1.02B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.